Sugar-Based Excipients Market Report 2026

Sugar-Based Excipients Market Overview

• Sugar-Based Excipients market size has reached to $1.49 billion in 2025 • Expected to grow to $1.81 billion in 2030 at a compound annual growth rate (CAGR) of 3.8% • Growth Driver: Rising Pharmaceutical Demand Boosts Growth Of The Market • Market Trend: The Role Of Mannitol In Optimizing Tablet Performance • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Sugar-Based Excipients Market?

Sugar-based excipients refer to a category of pharmaceutical excipients derived from sugars and their derivatives, such as sucrose, lactose, glucose, sorbitol, and mannitol. These excipients are used in drug formulations to perform various roles, enhancing the physical and chemical properties of medications and improving patient compliance. The main product types of sugar-based excipients are actual sugar, artificial sweeteners, and sugar alcohol. Actual sugars are natural carbohydrates, such as sucrose, glucose, and lactose, commonly used in pharmaceutical formulations to enhance taste, texture, and stability, improving the palatability and effectiveness of medications. These excipients are categorized based on dosage form into liquid, semi-solid, and solid formulations. They are used in various applications, including diluents, fillers, tonicity agents, and flavoring agents, serving end users in the pharmaceutical, food and beverage, and cosmetics and personal care industries.

What Is The Sugar-Based Excipients Market Growth Forecast?

The sugar-based excipients market size is expected to see steady growth in the next few years. It will grow to $1.81 billion in 2030 at a compound annual growth rate (CAGR) of 3.8%. The growth in the forecast period can be attributed to growing adoption of low-calorie and non-cariogenic excipients, rising demand for pediatric and geriatric formulations, expansion of biopharmaceutical production, focus on clean-label excipient sourcing, increasing investments in excipient innovation. Major trends in the forecast period include increasing use of sugar alcohol-based excipients, rising demand for patient-friendly formulations, growing adoption of multifunctional excipients, expansion of orally disintegrating dosage forms, enhanced focus on excipient purity standards.

What Is The Driver Of The Sugar-Based Excipients Market?

The growing popularity of pharmaceuticals is expected to propel the growth of the sugar-based excipients market going forward. The pharmaceutical industry focuses on the research, development, production, and marketing of medications to improve health outcomes. The pharmaceutical demand is growing due to increasing demand for innovative treatments, advancements in drug development technologies, and rising healthcare needs globally. Sugar-based excipients in pharmaceuticals act as fillers, binders, and stabilizers, enhancing drug formulation, taste, and bioavailability. For instance, in August 2025, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association representing the pharmaceutical industry, health industries invested about $281.2 billion (€258.1 billion) in R&D in 2023, accounting for 20.5% of total business R&D expenditure worldwide. Therefore, the growing popularity of pharmaceuticals is driving the growth of the sugar-based excipients industry.

Key Players In The Global Sugar-Based Excipients Market

Major companies operating in the sugar-based excipients market are Cargill Incorporated, Archer Daniels Midland Company, Associated British Foods PLC, DuPont de Nemours Inc., IFF Pharmaceuticals Solutions, Ingredion Incorporated, Tereos S.A., Roquette Frères S.A., IMCD N.V., Ashland Global Holdings Inc., Tate & Lyle PLC, Colorcon Inc., DFE Pharma, Emilio Castelli S.R.L., Pfanstiehl Inc., Meggle AG, Scope Ingredients Pvt. Ltd., Citron Scientific, MB Sugars & Pharmaceuticals, Prinova Group LLC, Global Sweeteners Holdings LLC, CSM Ingredients

Global Sugar-Based Excipients Market Trends and Insights

Major companies operating in the sugar-based excipients market are concentrating on developing innovative solutions, such as next-generation mannitol products, to enhance drug stability, improve solubility, and optimize formulation performance for pharmaceutical applications. Next-generation mannitol products are advanced mannitol formulations engineered to improve drug stability, increase solubility, and optimize tablet compression for superior pharmaceutical performance. For instance, in May 2023, Roquette, a France based supplier of plant based ingredients and pharmaceutical/nutraceutical excipients, introduced PEARLITOL® ProTec, a co processed mannitol maize starch excipient, at Vitafoods Europe. It features a measured water activity (Aw) of <0.20 and moisture content below 1% to stabilize probiotics and other moisture-sensitive actives. The excipient offers excellent compactability and flow properties, allowing its use in direct-compression tablets, stick packs, or sachets without additional drying steps. Fully compliant with major pharmacopeias, it is designed to help nutraceutical manufacturers meet stringent stability and regulatory requirements more efficiently.

What Are Latest Mergers And Acquisitions In The Sugar-Based Excipients Market?

In October 2023, Roquette Freres, a France-based food company, acquired Qualicaps Inc. for an undisclosed amount. With this acquisition, Roquette aims to expand its global footprint in the pharmaceutical industry, integrate its expertise in hard capsules, enhance its oral dosage solutions, strengthen its position in pharmaceutical excipients, and provide customers with a more diverse and innovative product range. Qualicaps Inc. is a US-based pharmaceutical company that designs, manufactures, and sells capsules like sugar-based excipients.

What Defines the Sugar-Based Excipients Market?

The sugar-based excipients market consists of sales of sucrose-based excipients, lactose-based excipients, and glucose-based excipients. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Sugar-Based Excipients Market Report 2026?

The sugar-based excipients market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the sugar-based excipients industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.